One To Watch
Boundless Bio
Boundless Bio is a biotechnology company seeking to develop novel therapies to treat cancer.
The firm is committed to: "interrogating a previously unexplored dimension in cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers."
Latest Boundless Bio News
Today's issue
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze